[PHARMA] YoY Quarter Result on 30-Sep-2024 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
26-Nov-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Sep-2024 [#3]
Profit Trend
QoQ- 3512.16%
YoY- 304.77%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 1,029,822 885,486 924,681 2,132,675 624,804 716,849 587,660 9.79%
PBT 138,485 -56,259 15,589 98,219 4,093 3,885 17,603 40.98%
Tax -37,166 7,212 -6,212 -47,895 -2,799 -3,509 -2,298 58.95%
NP 101,319 -49,047 9,377 50,324 1,294 376 15,305 36.98%
-
NP to SH 101,032 -49,339 8,617 49,835 1,442 481 15,051 37.30%
-
Tax Rate 26.84% - 39.85% 48.76% 68.39% 90.32% 13.05% -
Total Cost 928,503 934,533 915,304 2,082,351 623,510 716,473 572,355 8.38%
-
Net Worth -174,968 -245,740 411,327 391,428 345,040 516,387 522,618 -
Dividend
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Div - - 7,859 26,182 3,920 - 13,000 -
Div Payout % - - 91.21% 52.54% 271.91% - 86.38% -
Equity
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Net Worth -174,968 -245,740 411,327 391,428 345,040 516,387 522,618 -
NOSH 1,441,255 1,441,229 1,309,126 1,309,126 261,705 261,229 260,505 32.95%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 9.84% -5.54% 1.01% 2.36% 0.21% 0.05% 2.60% -
ROE 0.00% 0.00% 2.09% 12.73% 0.42% 0.09% 2.88% -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
RPS 71.45 65.94 70.59 162.91 239.03 274.86 226.02 -17.44%
EPS 7.01 -3.67 0.66 3.81 0.55 0.18 5.79 3.23%
DPS 0.00 0.00 0.60 2.00 1.50 0.00 5.00 -
NAPS -0.1214 -0.183 0.314 0.299 1.32 1.98 2.01 -
Adjusted Per Share Value based on latest NOSH - 1,441,255
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
RPS 71.45 61.44 64.16 147.97 43.35 49.74 40.77 9.79%
EPS 7.01 -3.42 0.60 3.46 0.10 0.03 1.04 37.40%
DPS 0.00 0.00 0.55 1.82 0.27 0.00 0.90 -
NAPS -0.1214 -0.1705 0.2854 0.2716 0.2394 0.3583 0.3626 -
Price Multiplier on Financial Quarter End Date
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Date 30/09/24 29/09/23 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 -
Price 0.39 0.435 0.515 0.835 4.32 2.44 2.89 -
P/RPS 0.55 0.66 0.73 0.51 1.81 0.89 1.28 -13.12%
P/EPS 5.56 -11.84 78.29 21.93 783.09 1,322.99 49.93 -30.61%
EY 17.97 -8.45 1.28 4.56 0.13 0.08 2.00 44.13%
DY 0.00 0.00 1.17 2.40 0.35 0.00 1.73 -
P/NAPS 0.00 0.00 1.64 2.79 3.27 1.23 1.44 -
Price Multiplier on Announcement Date
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Date 26/11/24 29/11/23 24/11/22 19/11/21 19/11/20 20/11/19 19/11/18 -
Price 0.355 0.405 0.55 0.845 5.72 2.21 3.09 -
P/RPS 0.50 0.61 0.78 0.52 2.39 0.80 1.37 -15.45%
P/EPS 5.06 -11.02 83.61 22.20 1,036.87 1,198.28 53.38 -32.45%
EY 19.75 -9.07 1.20 4.51 0.10 0.08 1.87 48.06%
DY 0.00 0.00 1.09 2.37 0.26 0.00 1.62 -
P/NAPS 0.00 0.00 1.75 2.83 4.33 1.12 1.54 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment